Cardiology (Video) UCTV

COVID-19 was initially identified as a respiratory disease, but scientists now know that it also affects several other organs in the body, including the heart. Heart damage is a major determinant of COVID-19 related deaths, and even patients who experience only mild COVID-19 symptoms exhibit signs of cardiac dysfunction after recovery. UCSF researchers Todd McDevitt and Bruce Conklin explore how SARS-CoV-2, the virus that causes COVID-19, inflicts damage on heart cells. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 36499]

Deborah K. Lieu, PhD
UC Davis Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36335]

After a heart attack and triple bypass surgery at age 60, Pat Farrant learned he had an inherited heart condition. He now dedicates his time to raising awareness about heart disease an its warning signs. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36434]

Can we discover new therapies for the heart with stem cells? From finding safer medication to preventing cardiac arrest, experts share the latest in the field of cardiac stem cell research.

Moderated by Anthony DeMaria, MD, UC San Diego
Pat Farrant: Patient Perspective
Deepak Srivastava, MD, Gladstone Institutes: Cellular Reprogramming Approaches for Heart Disease
Mark Mercola, PhD, Stanford University: Induced Pluripotent Stem Cell (iPSC)-derived Cardiomyocytes for Predicting and Removing Drug Cardiotoxicity
Deborah K. Lieu, PhD, UC Davis: The quest for pacemaking cardiomyocytes to engineer biopacemakers Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36336]

Deepak Srivastava, MD
Gladstone Institutes Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36333]

Mark Mercola, PhD
Stanford University Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36334]